trans-Clopenthixol is a typical antipsychotic drug of the thioxanthene class. Clopenthixol is composed of a mixture of cis-clopenthixol and trans-clopenthixol. The two isomers do not differ in several pharmacological properties, for instance, anti-noradrenergic effect. However, cis-clopenthixol possesses anti-dopaminergic effects, while trans-Clopenthixol not. Cis-Clopenthixol indicated for the management of the manifestations of schizophrenia and other mental illnesses with disturbances in thinking, emotional reactions and behavior.
Approval Year
PubMed
| Title | Date | PubMed |
|---|---|---|
| The bucco-linguo-masticatory syndrome as a side-effect of neuroleptics therapy. | 1967 |
|
| Prolonged oculogyric crisis on addition of nifedipine to neuroleptic medication regime. | 1987 Jan |
|
| Zuclopenthixol and haloperidol/levomepromazine in the treatment of elderly patients with symptoms of aggressiveness and agitation: a double-blind, multi-centre study. | 1989 |
|
| Zuclopenthixol, a combined dopamine D1/D2 antagonist, versus haloperidol, a dopamine D2 antagonist, in tardive dyskinesia. | 1991 Dec |
|
| [acute dystonias in combined abuse of cocaine and neuroleptics]. | 1994 Nov 26 |
|
| Effect of some psychotropic drugs and a barbiturate on mycoplasmas. | 2000 Apr |
|
| Clozapine and weight gain. | 2001 May |
|
| Long term results of unilateral posteroventral pallidotomy for antipsychotic drug induced tardive dyskinesia. | 2005 Jul |
|
| [Trazodone for the treatment of behavioral and psychological symptoms of dementia (BPSD) in Alzheimer's disease: a retrospective study focused on the aggression and negativism in caregiving situations]. | 2006 Jun |
|
| Fatal exertional heat stroke in a patient receiving zuclopenthixol, quetiapine and benztropine. | 2007 Fall |
|
| Severe laryngeal dystonia in a patient receiving zuclopenthixol "Acuphase" and fluoxetine. | 2010 Apr |
|
| Simultaneous determination of 25 common pharmaceuticals in whole blood using ultra-performance liquid chromatography-tandem mass spectrometry. | 2012 Sep |
|
| Comparative analysis of anti-toxoplasmic activity of antipsychotic drugs and valproate. | 2014 Mar |
|
| Paradoxical severe agitation induced by add-on high-doses quetiapine in schizo-affective disorder. | 2014 May 15 |
Patents
| Substance Class |
Mixture
Created
by
admin
on
Edited
Fri Dec 15 22:07:11 GMT 2023
by
admin
on
Fri Dec 15 22:07:11 GMT 2023
|
| Record UNII |
R3BMY435Z0
|
| Record Status |
Validated (UNII)
|
| Record Version |
|
-
Download
| Name | Type | Language | ||
|---|---|---|---|---|
|
Common Name | English | ||
|
Common Name | English | ||
|
Code | English | ||
|
Code | English | ||
|
Code | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Code | English |
| Code System | Code | Type | Description | ||
|---|---|---|---|---|---|
|
211-194-3
Created by
admin on Fri Dec 15 22:07:11 GMT 2023 , Edited by admin on Fri Dec 15 22:07:11 GMT 2023
|
PRIMARY | |||
|
169185
Created by
admin on Fri Dec 15 22:07:11 GMT 2023 , Edited by admin on Fri Dec 15 22:07:11 GMT 2023
|
PRIMARY | |||
|
m3653
Created by
admin on Fri Dec 15 22:07:11 GMT 2023 , Edited by admin on Fri Dec 15 22:07:11 GMT 2023
|
PRIMARY | Merck Index | ||
|
633-59-0
Created by
admin on Fri Dec 15 22:07:11 GMT 2023 , Edited by admin on Fri Dec 15 22:07:11 GMT 2023
|
PRIMARY | |||
|
SUB20303
Created by
admin on Fri Dec 15 22:07:11 GMT 2023 , Edited by admin on Fri Dec 15 22:07:11 GMT 2023
|
PRIMARY | |||
|
DTXSID60110058
Created by
admin on Fri Dec 15 22:07:11 GMT 2023 , Edited by admin on Fri Dec 15 22:07:11 GMT 2023
|
PRIMARY | |||
|
R3BMY435Z0
Created by
admin on Fri Dec 15 22:07:11 GMT 2023 , Edited by admin on Fri Dec 15 22:07:11 GMT 2023
|
PRIMARY | |||
|
78203
Created by
admin on Fri Dec 15 22:07:11 GMT 2023 , Edited by admin on Fri Dec 15 22:07:11 GMT 2023
|
PRIMARY |
All of the following components must be present:
| Related Record | Type | Details | ||
|---|---|---|---|---|
|
|
ACTIVE MOIETY |
